We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
AUM
$489M
AUM Growth
+$46.3M
Cap. Flow
+$27.5M
Cap. Flow %
5.62%
Top 10 Hldgs %
17.69%
Holding
426
New
27
Increased
339
Reduced
52
Closed
7

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.98M
2
WFC icon
Wells Fargo
WFC
+$1.97M
3
T icon
AT&T
T
+$1.81M
4
HPQ icon
HP
HPQ
+$1.18M
5
COP icon
ConocoPhillips
COP
+$1.14M

Sector Composition

Rank Sector Weight
1 Financials 16.1%
2 Technology 14.15%
3 Healthcare 12.88%
4 Industrials 9.53%
5 Consumer Staples 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
101
Lowe's Companies
LOW
$125B
$1.43M 0.29%
20,754
+349
+2% +$20.9K
DD
102
DELISTED
Du Pont De Nemours E I
DD
$1.43M 0.29%
20,342
+442
+2% +$29.5K
LMT icon
103
Lockheed Martin
LMT
$136B
$1.42M 0.29%
7,365
-5,425
-42% -$1.01M
WBA
104
DELISTED
Walgreens Boots Alliance
WBA
$1.41M 0.29%
18,538
+343
+2% +$22.9K
NEE icon
105
NextEra Energy
NEE
$177B
$1.41M 0.29%
52,916
+2,504
+5% +$63.2K
SBUX icon
106
Starbucks
SBUX
$120B
$1.37M 0.28%
33,490
+2,046
+7% +$79.9K
AGN
107
DELISTED
Allergan plc
AGN
$1.36M 0.28%
5,281
+208
+4% +$52K
EBAY icon
108
eBay
EBAY
$49.8B
$1.35M 0.28%
57,273
+1,848
+3% +$41.9K
AGN
109
DELISTED
Allergan Inc
AGN
$1.35M 0.28%
6,349
+221
+4% +$43.9K
LLY icon
110
Eli Lilly
LLY
$1.06T
$1.35M 0.28%
19,519
+671
+4% +$45.3K
ESRX
111
DELISTED
Express Scripts Holding Company
ESRX
$1.33M 0.27%
15,655
+266
+2% +$20.8K
ACN icon
112
Accenture
ACN
$108B
$1.32M 0.27%
14,810
-778
-5% -$64.6K
BLK icon
113
Blackrock
BLK
$176B
$1.32M 0.27%
3,680
+184
+5% +$62.9K
BKNG icon
114
Booking.com
BKNG
$161B
$1.3M 0.27%
28,550
+1,150
+4% +$51.9K
MDLZ icon
115
Mondelez International
MDLZ
$79.9B
$1.3M 0.27%
35,827
+987
+3% +$35.9K
EMC
116
DELISTED
EMC CORPORATION
EMC
$1.29M 0.26%
43,385
+1,459
+3% +$42.5K
MON
117
DELISTED
Monsanto Co
MON
$1.28M 0.26%
10,686
-693
-6% -$80.5K
F icon
118
Ford
F
$55.7B
$1.27M 0.26%
82,055
+1,935
+2% +$28.5K
CL icon
119
Colgate-Palmolive
CL
$74.4B
$1.26M 0.26%
18,264
+514
+3% +$34.7K
MS icon
120
Morgan Stanley
MS
$340B
$1.26M 0.26%
32,555
+910
+3% +$32.4K
DUK icon
121
Duke Energy
DUK
$97.3B
$1.26M 0.26%
15,070
+452
+3% +$36.4K
KIM icon
122
Kimco Realty
KIM
$16.4B
$1.24M 0.25%
+49,476
New +$1.21M
KEY icon
123
KeyCorp
KEY
$24.4B
$1.24M 0.25%
89,221
+338
+0.4% +$4.5K
JCI icon
124
Johnson Controls International
JCI
$92.2B
$1.24M 0.25%
24,433
-3,950
-14% -$193K
AET
125
DELISTED
Aetna Inc
AET
$1.23M 0.25%
13,885
-1,305
-9% -$110K

Similar funds

ClearArc Capital's Q4 2014 Portfolio in Review

As of Q4 2014, ClearArc Capital held 426 positions worth $489M, up 10% from $443M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ClearArc Capital deployed $27.5M of net new capital in Q4 2014, opening 27 new positions and adding to 339 existing holdings. Its largest new stake was DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA): 71,280 shares worth $4.28M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M trimmed.

  • ClearArc Capital's largest Q4 2014 buy was DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA): 71,280 shares worth $4.28M.
  • ClearArc Capital added most to WisdomTree Japan Hedged Equity Fund in Q4 2014, an estimated $4.11M increase.
  • ClearArc Capital's biggest Q4 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $1.98M.
  • ClearArc Capital fully exited Range Resources in Q4 2014, selling an estimated $235K.
  • ClearArc Capital's ten largest holdings make up 18% of its $489M portfolio in Q4 2014.
  • ClearArc Capital opened 27 new positions and closed 7 in Q4 2014.
  • ClearArc Capital's portfolio value rose 10% quarter-over-quarter to $489M.

Based on ClearArc Capital's 13F filing for Q4 2014, filed 13 Feb 2015.